In a small study, 80% of testicular cancer patients developed paraneoplastic neurologic syndromes before their cancer diagnosis — highlighting a need for early detection.

The UK has launched the world’s largest Parkinson’s trial (£26M EJS ACT-PD) to find treatments that slow disease progression.

Dr. Saswat Das, a Children’s Mercy pediatric cardiologist, is recovering after a hit-and-run crash. Police seek the driver of ...

A central Iowa nursing home has been cited for an incident in which a resident’s family member had to summon the police to ...

Scientists at Scripps Research identified an unusually active region of the brain linked to alcohol withdrawal symptoms in ...

Kathryn Harne, Outreach Coordinator for St. Joseph's/Candler Movement Disorders Program, sat down with WSAV's Kim Gusby to ...

H. Lundbeck A/S (Lundbeck) and Contera Pharma today announced a strategic research collaboration aiming to accelerate the discovery and development of innovative oligonucleotide-based medicines for ...

Experts suggest the real problem isn't the hours you're spending in bed: it's what's happening while you sleep ...

Revalesio, a clinical-stage pharmaceutical company pioneering neuroprotective therapies for neurological disorders, today announced that data from a post hoc analysis of the RESCUE Phase 2 clinical ...

Dysautonomia is a neurological illness that affects millions of people around the world. Yet, it isn't widely known or ...

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and ...

The Middle East pharmaceutical market offers significant opportunities due to rising chronic diseases, local production ...